Capas, Baby Girl M.

HRN: 26-72-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/19/2025
03/01/2025
PO
6mL
Q8h
Intestinal Amoebiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: